Sargramostim (GM-CSF) for induction of remission in Crohn's disease: a cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials

Inflammatory Bowel Diseases
Lee RothNilesh Chande

Abstract

We planned to systematically review the efficacy of sargramostim (granulocyte colony stimulating factor [GM-CSF]) for remission induction in patients with Crohn's disease (CD). A literature search to April 2011 was performed to identify all randomized trials studying sargramostim in patients with CD. The Cochrane risk of bias tool was used to evaluate study quality and the GRADE criteria were utilized to assess the overall quality of the evidence. Three randomized studies (total 537 patients) were identified. The risk of bias was low for the three included studies. There was no statistically significant difference in the proportion of patients who achieved clinical remission (GM-CSF 25.3%; placebo 17.5%; relative risk [RR] 1.67; 95% confidence interval [CI] 0.80-3.50; P = 0.17), or 100-point clinical response (GM-CSF 38.3%; placebo 24.8%; RR 1.71 95% CI 0.98-2.97; P = 0.06). There was no statistically significant difference in the proportion of patients (GM-CSF 95.8%; placebo 89.3%) who experienced adverse events (RR 1.07; 95% CI 0.99-1.16; P = 0.08), or serious adverse events (GM-CSF 12.0% vs. placebo 4.8%; RR 2.21; 95% CI 0.84-5.81; P = 0.11). Sargramostim does not appear to be more effective than placebo for induction of cli...Continue Reading

References

Jan 23, 1999·The New England Journal of Medicine·D Vaughan, B Drumm
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Feb 16, 2005·Alimentary Pharmacology & Therapeutics·J R Korzenik, B K Dieckgraefe
May 27, 2005·The New England Journal of Medicine·Joshua R KorzenikUNKNOWN Sargramostim in Crohn's Disease Study Group
Dec 14, 2005·Gastroenterology·Alan C Moss, Richard J Farrell
Jul 20, 2007·The New England Journal of Medicine·William J SandbornUNKNOWN PRECISE 1 Study Investigators
Apr 26, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
Apr 9, 2009·Journal of Gastroenterology·Masakazu TakazoeMamoru Watanabe

❮ Previous
Next ❯

Citations

Nov 25, 2014·Expert Opinion on Pharmacotherapy·Andrea AffrontiMario Cottone
Jan 24, 2014·Expert Opinion on Biological Therapy·Klaus R HerrlingerKlaus Fellermann
Oct 30, 2015·Proceedings of the National Academy of Sciences of the United States of America·Lioba F CourthJan Wehkamp
Sep 25, 2012·Trends in Immunology·John A Hamilton, Adrian Achuthan
Mar 25, 2015·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Palash BhattacharyaBellur S Prabhakar
Jun 15, 2015·Bioinformatics·Yang ChenRong Xu
Apr 4, 2015·Mediators of Inflammation·Aoi Shiomi, Takashi Usui
Sep 16, 2016·PLoS Neglected Tropical Diseases·Neima BriggsPeter J Hotez
Aug 12, 2014·Gastroenterology Clinics of North America·Uri Kopylov, Waqqas Afif
Dec 22, 2016·Journal of Clinical Medicine·Odile WéraCécile Oury
Jun 23, 2018·European Journal of Clinical Investigation·Anthony W Segal
Jul 5, 2016·Inflammation and Regeneration·Aoi ShiomiTsuneyo Mimori
Oct 16, 2019·The Journal of Experimental Medicine·John A Hamilton
Jan 23, 2013·Current Opinion in Gastroenterology·Philip Rosenstiel
Feb 6, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jan DäbritzDirk Foell
Aug 9, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hrishikesh M MehtaSeth J Corey
Feb 8, 2014·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jan Däbritz
Oct 31, 2017·Frontiers in Immunology·Alessandra Geremia, Carolina V Arancibia-Cárcamo
Apr 8, 2020·Frontiers in Immunology·Charles Caër, Mary Jo Wick
Feb 17, 2019·International Journal of Molecular Sciences·Francesco BorrielloGianni Marone
Jun 24, 2021·Journal of Crohn's & Colitis·Tim RaineGarret Cullen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Inflammatory Bowel Diseases
Judith R KelsenRobert N Baldassano
The Journal of Experimental Medicine
Thomas EnzlerGlenn Dranoff
Expert Review of Gastroenterology & Hepatology
Laia EgeaMartin F Kagnoff
© 2021 Meta ULC. All rights reserved